Cite
HARVARD Citation
Broglio, F. et al. (2017). Beneficial effect of lixisenatide after 76 weeks of treatment in patients with type 2 diabetes mellitus: A meta‐analysis from the GetGoal programme. Diabetes, obesity & metabolism. 19 (2), pp. 248-256. [Online].